The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2018. This month there is one guideline and one technology appraisal that impact upon primary care.
The Dementia guideline has been published. It replaces a previous guideline from 2006 and covers diagnosing and managing dementia (including Alzheimer's disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.
The Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease technology appraisal has been updated with the recommendations in section 1.3 replaced by the guideline above.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« SMC Update - June 2018||Drug Safety Update - June 2018 »|